Published in Br J Ophthalmol on March 01, 1992
Functional endoscopic sinus surgery: indications and complications in the ophthalmic field. Oman Med J (2009) 1.03
Function of transected or avulsed rectus muscles following recovery using an anterior orbitotomy approach. J AAPOS (2012) 0.82
Adjustable sutures in squint surgery. Br J Ophthalmol (1992) 0.82
An Approach to Some Aspects of Strabismus from Ocular and Orbital Trauma. Middle East Afr J Ophthalmol (2015) 0.81
Traumatic tear of the inferior rectus muscle treated with inferior oblique anterior transposition. Int Ophthalmol (2007) 0.81
Surgical results of the slipped medial rectus muscle after hang back recession surgery. Int J Ophthalmol (2014) 0.79
What information can we give to the patient about the risks of strabismus surgery. Eye (Lond) (2015) 0.75
Isolated Total Rupture of Extraocular Muscles. Medicine (Baltimore) (2015) 0.75
Recognition and repair of the "lost" rectus muscle. A report of 25 cases. Ophthalmology (1990) 2.13
The oculocardiac reflex as a surgical aid in identifying a slipped or 'lost' extraocular muscle. Br J Ophthalmol (1980) 1.37
Disinserted extraocular muscles. Am J Ophthalmol (1975) 1.16
Extraocular muscle lacerations. Am J Ophthalmol (1976) 1.16
Regulation of pancreatic beta-cell growth and survival by the serine/threonine protein kinase Akt1/PKBalpha. Nat Med (2001) 4.07
Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science (2000) 3.12
Folding transition in the DNA-binding domain of GCN4 on specific binding to DNA. Nature (1990) 2.97
Association between Graves' ophthalmopathy and smoking. Lancet (1990) 2.62
Alzheimer's disease amyloid propagation by a template-dependent dock-lock mechanism. Biochemistry (2000) 2.37
The Alzheimer's peptide a beta adopts a collapsed coil structure in water. J Struct Biol (2000) 2.26
Purification of the enzyme reducing bisulfite to trithionate from Desulfovibrio gigas and its identification as desulfoviridin. Biochem Biophys Res Commun (1971) 1.81
T cells and fibroblasts in affected extraocular muscles in early and late thyroid associated ophthalmopathy. Br J Ophthalmol (2000) 1.59
Point substitution in the central hydrophobic cluster of a human beta-amyloid congener disrupts peptide folding and abolishes plaque competence. Biochemistry (1996) 1.58
Simulation study of the structure and dynamics of the Alzheimer's amyloid peptide congener in solution. Biophys J (2001) 1.45
Isolation of a new pigment, desulforubidin, from Desulfovibrio desulfuricans (Norway strain) and its role in sulfite reduction. J Bacteriol (1973) 1.43
Spag4, a novel sperm protein, binds outer dense-fiber protein Odf1 and localizes to microtubules of manchette and axoneme. Dev Biol (1999) 1.42
Review of the inverse Knapp procedure: indications, effectiveness and results. Eye (Lond) (2001) 1.39
Monocular elevation paresis caused by a central nervous system lesion. Arch Ophthalmol (1968) 1.29
Isolation of assimilatroy- and dissimilatory-type sulfite reductases from Desulfovibrio vulgaris. J Bacteriol (1973) 1.28
Deposition of monomeric, not oligomeric, Abeta mediates growth of Alzheimer's disease amyloid plaques in human brain preparations. Biochemistry (1999) 1.27
Calpains play a role in insulin secretion and action. Diabetes (2001) 1.25
Characterization of the major brain osmolytes that accumulate in salt-loaded rats. Am J Physiol (1989) 1.21
Ocular complications of self-induced vitamin A deficiency. Trans Ophthalmol Soc U K (1970) 1.21
Activation barriers to structural transition determine deposition rates of Alzheimer's disease a beta amyloid. J Struct Biol (2000) 1.20
Immunohistochemical analysis of the retrobulbar tissues in Graves' ophthalmopathy. Clin Exp Immunol (1989) 1.20
In vitro growth of Alzheimer's disease beta-amyloid plaques displays first-order kinetics. Biochemistry (1996) 1.19
Extraocular muscle surgery in myasthenia gravis. Br J Ophthalmol (1991) 1.15
Detection and characterization of a phospholactoyl-enzyme adduct in the reaction catalyzed by UDP-N-acetylglucosamine enolpyruvoyl transferase, MurZ. Biochemistry (1994) 1.13
Deterioration of severe Graves' ophthalmopathy during cyclosporin treatment. Lancet (1984) 1.12
Causes and outcomes for patients presenting with diplopia to an eye casualty department. Eye (Lond) (2006) 1.12
Reversal of the complications of self-induced vitamin A deficiency. Br J Ophthalmol (1971) 1.10
Mutant superoxide dismutase-1-linked familial amyotrophic lateral sclerosis: molecular mechanisms of neuronal death and protection. J Neurosci (1997) 1.09
The effects of strabismus surgery on anterior segment circulation. Eye (Lond) (1989) 1.09
Surgical management of dysthyroid eye disease: a review. Proc R Soc Med (1977) 1.08
Elevating the hypotropic globe. Br J Ophthalmol (1986) 1.06
The use of adjustable sutures. Trans Ophthalmol Soc U K (1981) 1.05
An iron tetrahydroporphyrin prosthetic group common to both assimilatory and dissimilatory sulfite reductases. Biochem Biophys Res Commun (1973) 1.05
Treatment of strabismus in adults with botulinum toxin A. Br J Ophthalmol (1985) 1.05
Botulinum toxin A induced protective ptosis. Eye (Lond) (1987) 1.04
Role of botulinum toxin A in surgically overcorrected exotropia. J AAPOS (1999) 1.04
The Saccharomyces cerevisiae SPT14 gene is essential for normal expression of the yeast transposon, Ty, as well as for expression of the HIS4 gene and several genes in the mating pathway. Mol Gen Genet (1991) 1.04
Mutation analysis of PTEN/MMAC1 in acute myeloid leukemia. Am J Hematol (2000) 1.04
Evidence for the involvement of non-heme iron in the active site of hydrogenase from Desulfovibrio vulgaris. Biochim Biophys Acta (1971) 1.03
Sonographic findings of placental lacunae and the prediction of adherent placenta in women with placenta previa totalis and prior Cesarean section. Ultrasound Obstet Gynecol (2006) 1.03
Apolipoprotein A-I domains involved in lecithin-cholesterol acyltransferase activation. Structure:function relationships. J Biol Chem (1993) 1.02
Residual structure in the Alzheimer's disease peptide: probing the origin of a central hydrophobic cluster. Fold Des (1998) 1.02
Recovery of anterior segment circulation after strabismus surgery in adult patients. Ophthalmology (1992) 1.01
RING-dependent tumor suppression and G2/M arrest induced by the TRC8 hereditary kidney cancer gene. Oncogene (2006) 1.01
The incidence of strabismus and refractive error in patients with blepharophimosis, ptosis and epicanthus inversus syndrome (BPES). Strabismus (2003) 1.00
Analysis of extraocular muscle-infiltrating T cells in thyroid-associated ophthalmopathy (TAO). Clin Exp Immunol (1997) 1.00
Antifungal activity of magnolol and honokiol. Arch Pharm Res (2000) 0.99
Cyclic strabismus without binocular function. J Pediatr Ophthalmol Strabismus (1993) 0.99
Orbital decompression for severe dysthyroid eye disease. Br J Ophthalmol (1987) 0.98
Active management in patients with ocular manifestations of myasthenia gravis. Eye (Lond) (2001) 0.98
Enzyme production of Trichoderma reesei Rut C-30 on various lignocellulosic substrates. Appl Biochem Biotechnol (2000) 0.96
Treatment of sixth nerve palsy in adults with combined botulinum toxin chemodenervation and surgery. Ophthalmology (1988) 0.96
Management of ipsilateral ptosis with hypotropia. Br J Ophthalmol (1986) 0.94
The use of botulinum toxin for treatment of acquired nystagmus and oscillopsia. Ophthalmology (1994) 0.93
Intensive occlusion therapy for amblyopia. Br J Ophthalmol (2001) 0.93
Botulinum toxin in fourth nerve palsies. Aust N Z J Ophthalmol (1997) 0.93
Immunogenetics of Graves' ophthalmopathy. Clin Endocrinol (Oxf) (1988) 0.93
Botulinum toxin A-induced protective ptosis in corneal disease. Ophthalmology (1988) 0.93
Intragenic suppression of a luxR mutation: characterization of an autoinducer-independent LuxR. FEMS Microbiol Lett (1995) 0.92
Diagnosis and management of dysthyroid exophthalmos. Mod Probl Ophthalmol (1975) 0.92
Adhesion molecule expression in vivo on extraocular muscles (EOM) in thyroid-associated ophthalmopathy (TAO). Clin Exp Immunol (1997) 0.92
Persisting hypotropias following protective ptosis induced by botulinum neurotoxin. Eye (Lond) (1994) 0.91
Management of paralytic strabismus. Br J Ophthalmol (1974) 0.91
Isolation of a protein containing tightly bound 5-methoxybenzimidazolylcobamide (factor 3m) from Clostridium thermoaceticum. Biochemistry (1973) 0.91
Cytotoxic triterpenes from Crataegus pinnatifida. Arch Pharm Res (2000) 0.90
Long-term follow-up of orbital blow-out fractures with and without surgery. Mod Probl Ophthalmol (1975) 0.89
Early experience with adjustable squint surgery at Moorfields Eye Hospital with long-term follow-up. Trans Ophthalmol Soc U K (1985) 0.89
Orbital decompression for thyroid eye disease: a comparison of external and endoscopic techniques. J Laryngol Otol (1997) 0.89
Long-term results of botulinum toxin in consecutive and secondary exotropia: outcome in patients initially treated with botulinum toxin. J AAPOS (1998) 0.89
Chorioretinal scarring following the Faden operation. A retrospective study of 100 procedures. Eye (Lond) (1989) 0.89
Results of superior oblique posterior tenotomy. J AAPOS (1998) 0.89
Motion detection deficits in infantile esotropia without nystagmus. Invest Ophthalmol Vis Sci (1997) 0.89
Intraocular penetration of cephaloridine. Br J Ophthalmol (1972) 0.89
Reactivity of Desulfovibrio gigas hydrogenase toward artificial and natural electron donors or acceptors. Biochimie (1978) 0.89
Segmental colonic dilatation in a neonate. J Pediatr Surg (1992) 0.89
Association of familial Duane anomaly and urogenital abnormalities with a bisatellited marker derived from chromosome 22. Am J Med Genet (1993) 0.89
Binocular diplopia in unilateral aphakia: the role of botulinum toxin. Eye (Lond) (1991) 0.89
Botulinum toxin therapy in dysthyroid strabismus. Eye (Lond) (1990) 0.88
Residual symptomatic superior oblique palsy. Strabismus (2007) 0.88
Phacoemulsification and opaque intraocular lens implantation for the treatment of intractable diplopia. Ophthalmic Surg Lasers (2001) 0.87
Morphological effects of ArF excimer laser irradiation on enamel and dentin. Lasers Surg Med (1997) 0.87
Further studies on the biosynthesis of chlorothricin. J Antibiot (Tokyo) (1986) 0.87
A vermiculating tumour of the orbit. Trans Ophthalmol Soc U K (1970) 0.86
Incidence of inadvertent globe perforation during strabismus surgery. Br J Ophthalmol (1990) 0.85
Assessment and management of bilateral superior oblique pareses. Trans Ophthalmol Soc U K (1980) 0.85
Cyclic oculomotor palsy. Trans Ophthalmol Soc U K (1979) 0.85
Surgical management of excyclotorison. Int Ophthalmol Clin (1976) 0.85
Disinsertion of the inferior oblique muscle for treatment of superior oblique paresis. J Pediatr Ophthalmol Strabismus (2001) 0.85
The diagnosis and surgical management of acquired bilateral superior oblique palsy. Eye (Lond) (1987) 0.84
Duane's retraction syndrome and juvenile Batten's disease: a new association? Aust N Z J Ophthalmol (1998) 0.84
A scoring method for Hess charts. Eye (Lond) (1992) 0.84
Management of strabismus due to orbital myositis. Eye (Lond) (1995) 0.83
The role of plain radiography in the management of suspected orbital blow-out fractures. Br J Radiol (1997) 0.83
New antimicrobial flavanones from Physena madagascariensis. J Nat Prod (2000) 0.83
Ocular motility disturbances after surgery for retinal detachment. J AAPOS (1998) 0.82
Identification of the effects of aging-related gene-matrix metalloproteinase on allograft outcomes in kidney transplantation. Transplant Proc (2013) 0.82